Biology:MPGES-1

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example


Microsomal prostaglandin E synthase-1 (mPGES-1)[1][2] or Prostaglandin E synthase is an enzyme that in humans is encoded by the PTGES gene.[3][4][5]

The protein encoded by this gene is a glutathione-dependent prostaglandin E synthase. The expression of this gene has been shown to be induced by proinflammatory cytokine interleukin 1 beta (IL1B). Its expression can also be induced by tumor suppressor protein TP53, and may be involved in TP53-induced apoptosis.

Knockout studies in mice suggest that this gene may contribute to the pathogenesis of collagen-induced arthritis and mediate acute pain during inflammatory responses.[5]

It is inhibited by crisdesalazine (AAD-2004; GedaCure).[6]

See also

References

  1. "Identification of human prostaglandin E synthase: a microsomal glutathione-dependent, inducible enzyme, constituting a potential novel drug target.". Proc Natl Acad Sci USA 96 (13): 7220–7225. 1989. doi:10.1073/pnas.96.13.7220. PMID 10377395. Bibcode1999PNAS...96.7220J. 
  2. Hui-Hua Chang; Emmanuelle J Meuillet (2011). "Identification and development of mPGES-1 inhibitors: where we are at?". Future Med Chem 3 (15): 1909–1934. doi:10.4155/fmc.11.136. PMID 22023034. 
  3. "A model for p53-induced apoptosis". Nature 389 (6648): 300–5. Sep 1997. doi:10.1038/38525. PMID 9305847. Bibcode1997Natur.389..300P. 
  4. "Common structural features of MAPEG -- a widespread superfamily of membrane-associated proteins with highly divergent functions in eicosanoid and glutathione metabolism". Protein Sci 8 (3): 689–92. May 1999. doi:10.1110/ps.8.3.689. PMID 10091672. 
  5. 5.0 5.1 "Entrez Gene: PTGES prostaglandin E synthase". https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=9536. 
  6. "Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis". Expert Opin Investig Drugs 21 (9): 1267–308. September 2012. doi:10.1517/13543784.2012.703178. PMID 22741814. 

Further reading